Intellihealth Solutions Private Limited (d/b/a Truemeds) has raised ~₹745 crore ($85 million) from a Series C fundraise led by Accel and Peak XV Partners, with participation from existing investors WestBridge and InfoEdge Ventures.
JSA Advocates & Solicitors advised Truemeds and its Founders on this fundraise.
The transaction team was Rishabh Gupta (Partner), Akshath Mithal (Principal Associate), Tanmayee Shriprasad Apte (Associate), and Saurabh Chatterji (Associate).
Khaitan & Co advised lead investor Peak XV Partners Growth Investments IV on this fundraise as well as existing investor InfoEdge Ventures on this fundraise.
The transaction team advising Peak XV Partners consisted of Bharat Anand (Senior Partner), Nidhi Killawala (Partner), Mukul Aggarwal (Partner), Shatakshi Gupta (Senior Associate) and Sakshi Garg (Associate). The team was further supported by Ishaan Chopra (Senior Associate) on legal due diligence and regulatory aspects, Nirupam Lodha (Partner) on intellectual property aspects and Pranjal Prateek on competition law aspects.
The core transaction team advising Info Edge Venture Fund consisted of Sanchit Agarwal (Partner), Pulkit Chaturvedi (Principal Associate), Chirag Mangal (Senior Associate), Jubin Jay (Senior Associate) and Prerna Kapur (Senior Associate).
TT&A advised existing investor WestBridge Capital (WestBridge AIF I along with co-investors MMPL Trust and Konark Trust) on this fundraise.
The transaction team consisted of Gautam Saha (Managing Partner), Amrita Patnaik (Partner), Harshit Chandra (Partner), Utsav Agarwal (Managing Associate), Shambhavi Singh (Senior Associate) and Radhika Sarda (Associate).
Truemeds is a leading telehealth platform providing generic and substitute medicines, and is focused on enabling greater affordability in healthcare access.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.